| Steroids affect collateral sensitivity to gemcitabine of multidrug-resistant human lung cancer cells. | |
| | |
MedLine Citation:
|
PMID: 11282108 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Gemcitabine is phosphorylated by deoxycytidine kinase and thymidine kinase 2 and during S-phase incorporated into DNA. The steroids cortisol and dexamethasone, which regulate cell proliferation and gene expression, are pumped out of the cell by the membrane efflux pumps P-glycoprotein and multidrug resistance-associated protein (MRP), which are blocked by verapamil. In parental non-small cell lung cancer (NSCLC) cells (SW1573), 5 microM cortisol and 100 nM dexamethasone decreased sensitivity to gemcitabine. However, both cortisol and dexamethasone only decreased sensitivity with verapamil in MRP (2R120) and P-glycoprotein (2R160) overexpressing variants. Cortisol decreased deoxycytidine kinase activity in SW1573 cells and cortisol with verapamil in 2R120 and 2R160 cells. Dexamethasone with verapamil decreased deoxycytidine kinase activity in 2R160. Cortisol decreased thymidine kinase 2 activity in 2R120 and 2R160 cells. Dexamethasone decreased thymidine kinase 2 activity in SW1573, 2R120 and 2R160 cells. In conclusion, since dexamethasone is frequently used to treat side effects of oncolytic therapy, a decrease of sensitivity to gemcitabine by steroids might be clinically relevant. |
| | |
Authors:
|
A M Bergman; H M Pinedo; G J Peters |
Related Documents
:
|
18288958 - Genuine functions of p-glycoprotein (abcb1). 15360048 - Differential effects of toremifene on doxorubicin, vinblastine and tc-99m-sestamibi in ... 20732098 - Comparison of ldh, (51)cr, and bcecf efflux as indices of non-steroidal anti-inflammato... 20455578 - Cytotoxic effects of tanshinones from salvia miltiorrhiza on doxorubicin-resistant huma... 8947468 - Importance of catalase in the adaptive response to hydrogen peroxide: analysis of acata... 3297968 - Malignant osteoclastoma-like giant cell tumour of the renal pelvis. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: European journal of pharmacology Volume: 416 ISSN: 0014-2999 ISO Abbreviation: Eur. J. Pharmacol. Publication Date: 2001 Mar |
Date Detail:
|
Created Date: 2001-04-03 Completed Date: 2001-07-26 Revised Date: 2013-06-03 |
Medline Journal Info:
|
Nlm Unique ID: 1254354 Medline TA: Eur J Pharmacol Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 19-24 Citation Subset: IM |
Affiliation:
|
Department of Oncology, VU Medical Center, P.O. Box 7057, 1007 MB, Amsterdam, Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cell Division
/
drug effects Deoxycytidine / analogs & derivatives, pharmacology* Deoxycytidine Kinase / drug effects, metabolism Dexamethasone / pharmacology* Drug Interactions Drug Resistance, Multiple Humans Hydrocortisone / pharmacology* P-Glycoprotein / drug effects*, metabolism Tumor Cells, Cultured Verapamil / pharmacology |
| Chemical | |
Reg. No./Substance:
|
0/P-Glycoprotein; 50-02-2/Dexamethasone; 50-23-7/Hydrocortisone; 52-53-9/Verapamil; 951-77-9/Deoxycytidine; B76N6SBZ8R/gemcitabine; EC 2.7.1.74/Deoxycytidine Kinase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Phenol derivatives accelerate inactivation kinetics in one inactivation-deficient mutant human skele...
Next Document: Induction of apoptosis by esculetin in human leukemia cells.